30 programming-"the"-"DAAD"-"U"-"Prof"-"EURAXESS"-"MASARYK-UNIVERSITY" "UCL" Fellowship positions
Sort by
Refine Your Search
-
About us This position is a key part of the Vaccines Manufacturing Hub for LMICs (VaxHub Global), led by UCL Biochemical Engineering and the University of Oxford with several academic and industrial
-
how best to translate these findings into changes in practice and policy. The post is based within the Population Policy and Practice Programme (PPP) at the UCL Great Ormond Street Institute of Child
-
assistance programme: Staff Support Service Discounted medical insurance Visit https://www.ucl.ac.uk/work-at-ucl/rewards-and-benefits to find out more Our commitment to Equality, Diversity and Inclusion As
-
About us The UCL Cancer Institute is a £40 million investment in central London based at University College London (UCL), one of the world's top universities and a founding member of the Francis
-
policies were introduced, and there is a need to better understand their full and wider impacts. The proposed programme of work will evaluate, from a public health perspective, the impact of these two
-
and adoption pay Employee assistance programme: Staff Support Service Discounted medical insurance Visit https://www.ucl.ac.uk/work-at-ucl/reward-and-benefits to find out more. We will consider
-
Employee assistance programme: Staff Support Service Discounted medical insurance Visit https://www.ucl.ac.uk/work-at-ucl/reward-and-benefits to find out more. We will consider applications to work on a
-
About us About IOE IOE is UCL Faculty of Education and Society. Founded in 1902, IOE has been shaping policy and helping government, organisations and individuals navigate a changing society for the
-
Universities (Kent, Brunel, Loughborough and UCL) and seven industry partners. sChOOL YARD is funded by EPSRC and aims to develop model and guidelines that ensure outdoor spaces in schools provide comfort
-
: interoceptive mechanisms of anxiety after cancer’. The award is supporting a large-scale collaborative research programme between KCL, UCL, Stanford University, and the National Cancer Institute (NIH) through